GLOBAL AND CHINA BIOSIMILAR MARKET 2020 BY MANUFACTURERS, TYPE AND APPLICATION, FORECAST TO 2025

Mar 2020 93
Table of Contents

1 Market Overview
1.1 Biosimilar Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biosimilar Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Human Growth Hormones
1.2.3 Monoclonal Antibodies
1.2.4 Insulin
1.2.5 Peptides
1.2.6 Erythropoietin
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Biosimilar Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Chronic and Autoimmune Diseases
1.3.4 Growth Hormone Deficiency
1.3.5 Infectious Diseases
1.3.6 Others
1.4 Global Biosimilar Market Size and Forecast (2015-2025)
1.4.1 Global Biosimilar Revenue and Forecast (2015-2025)
1.4.2 Global Biosimilar Sales and Forecast (2015-2025)
1.5 Global Biosimilar Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Allergan plc
2.1.1 Allergan plc Details
2.1.2 Allergan plc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Allergan plc SWOT Analysis
2.1.4 Allergan plc Product and Services
2.1.5 Allergan plc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Dr. Reddy’s Laboratories
2.2.1 Dr. Reddy’s Laboratories Details
2.2.2 Dr. Reddy’s Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Dr. Reddy’s Laboratories SWOT Analysis
2.2.4 Dr. Reddy’s Laboratories Product and Services
2.2.5 Dr. Reddy’s Laboratories Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 BioXpress Therapeutics
2.3.1 BioXpress Therapeutics Details
2.3.2 BioXpress Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 BioXpress Therapeutics SWOT Analysis
2.3.4 BioXpress Therapeutics Product and Services
2.3.5 BioXpress Therapeutics Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 BIOCAD
2.4.1 BIOCAD Details
2.4.2 BIOCAD Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BIOCAD SWOT Analysis
2.4.4 BIOCAD Product and Services
2.4.5 BIOCAD Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Coherus BioSciences
2.5.1 Coherus BioSciences Details
2.5.2 Coherus BioSciences Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Coherus BioSciences SWOT Analysis
2.5.4 Coherus BioSciences Product and Services
2.5.5 Coherus BioSciences Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biocon
2.6.1 Biocon Details
2.6.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biocon SWOT Analysis
2.6.4 Biocon Product and Services
2.6.5 Biocon Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Intas Pharmaceuticals Limited
2.7.1 Intas Pharmaceuticals Limited Details
2.7.2 Intas Pharmaceuticals Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Intas Pharmaceuticals Limited SWOT Analysis
2.7.4 Intas Pharmaceuticals Limited Product and Services
2.7.5 Intas Pharmaceuticals Limited Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Celltrion
2.8.1 Celltrion Details
2.8.2 Celltrion Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Celltrion SWOT Analysis
2.8.4 Celltrion Product and Services
2.8.5 Celltrion Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Boehringer Ingelheim SWOT Analysis
2.9.4 Boehringer Ingelheim Product and Services
2.9.5 Boehringer Ingelheim Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Genor BioPharma
2.10.1 Genor BioPharma Details
2.10.2 Genor BioPharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Genor BioPharma SWOT Analysis
2.10.4 Genor BioPharma Product and Services
2.10.5 Genor BioPharma Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Novartis SWOT Analysis
2.11.4 Novartis Product and Services
2.11.5 Novartis Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Pfizer SWOT Analysis
2.12.4 Pfizer Product and Services
2.12.5 Pfizer Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Reliance Life Sciences
2.13.1 Reliance Life Sciences Details
2.13.2 Reliance Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Reliance Life Sciences SWOT Analysis
2.13.4 Reliance Life Sciences Product and Services
2.13.5 Reliance Life Sciences Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Biosimilar Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Biosimilar Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Biosimilar Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: China
3.2.1 Key Players Biosimilar Sales in China (2018-2019)
3.2.2 China Biosimilar Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Biosimilar Manufacturer Market Share in 2019
3.3.2 Top 6 Biosimilar Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Biosimilar Market Size by Geography (2015-2020)
4.1.1 Global Biosimilar Sales by Geography (2015-2020)
4.1.2 Global Biosimilar Revenue by Regions (2015-2020)
4.2 Global Biosimilar Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Biosimilar Sales and Forecast by Regions (2020-2025)
4.2.2 Global Biosimilar Revenue and Forecast by Regions (2020-2025)
4.3 North America Biosimilar Market Size and Forecast (2015-2025)
4.4 Europe Biosimilar Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Biosimilar Market Size and Forecast (2015-2025)
4.6 South America Biosimilar Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Biosimilar Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Biosimilar Market Size by Country (2015-2020)
5.1.1 North America Biosimilar Sales and Market Share by Country (2015-2020)
5.1.2 North America Biosimilar Revenue and Market Share by Country (2015-2020)
5.2 North America Biosimilar Market Size and Forecast by Country (2020-2025)
5.2.1 North America Biosimilar Sales and Forecast by Country (2020-2025)
5.2.2 North America Biosimilar Revenue and Forecast by Country (2020-2025)
5.3 United States Biosimilar Market Size and Forecast (2015-2025)
5.4 Canada Biosimilar Market Size and Forecast (2015-2025)
5.5 Mexico Biosimilar Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Biosimilar Market Size by Country (2015-2020)
6.1.1 Europe Biosimilar Sales by Country (2015-2020)
6.1.2 Europe Biosimilar Revenue by Country (2015-2020)
6.2 Europe Biosimilar Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Biosimilar Sales and Forecast by Country (2020-2025)
6.2.2 Europe Biosimilar Revenue and Forecast by Country (2020-2025)
6.3 Germany Biosimilar Market Size and Forecast (2015-2025)
6.4 United Kingdom Biosimilar Market Size and Forecast (2015-2025)
6.5 France Biosimilar Market Size and Forecast (2015-2025)
6.6 Russia Biosimilar Market Size and Forecast (2015-2025)
6.7 Italy Biosimilar Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Biosimilar Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Biosimilar Sales by Region (2015-2020)
7.1.2 Asia-Pacific Biosimilar Revenue by Region (2015-2020)
7.2 Asia-Pacific Biosimilar Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Biosimilar Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Biosimilar Revenue and Forecast by Region (2020-2025)
7.3 China Biosimilar Market Size and Forecast (2015-2025)
7.4 Japan Biosimilar Market Size and Forecast (2015-2025)
7.5 Korea Biosimilar Market Size and Forecast (2015-2025)
7.6 India Biosimilar Market Size and Forecast (2015-2025)
7.7 Southeast Asia Biosimilar Market Size and Forecast (2015-2025)
7.8 Australia Biosimilar Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Biosimilar Market Size by Country (2015-2020)
8.1.1 South America Biosimilar Sales by Country (2015-2020)
8.1.2 South America Biosimilar Revenue by Country (2015-2020)
8.2 South America Biosimilar Market Size and Forecast by Country (2020-2025)
8.2.1 South America Biosimilar Sales and Forecast by Country (2020-2025)
8.2.2 South America Biosimilar Revenue and Forecast by Country (2020-2025)
8.3 Brazil Biosimilar Market Size and Forecast (2015-2025)
8.4 Argentina Biosimilar Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Biosimilar Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Biosimilar Sales by Country (2015-2020)
9.1.2 Middle East & Africa Biosimilar Revenue by Country (2015-2020)
9.2 Middle East & Africa Biosimilar Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Biosimilar Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Biosimilar Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Biosimilar Market Size and Forecast (2015-2025)
9.4 Turkey Biosimilar Market Size and Forecast (2015-2025)
9.5 Egypt Biosimilar Market Size and Forecast (2015-2025)
9.6 South Africa Biosimilar Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Biosimilar Market Size by Type (2015-2020)
10.1.1 Global Biosimilar Sales by Type (2015-2020)
10.1.2 Global Biosimilar Revenue by Type (2015-2020)
10.1.3 Global Biosimilar Price by Type (2015-2020)
10.2 Global Biosimilar Market Size and Forecast by Type (2020-2025)
10.2.1 Global Biosimilar Sales and Forecast by Type (2020-2025)
10.2.2 Global Biosimilar Revenue and Forecast by Type (2020-2025)
10.2.3 Global Biosimilar Price and Forecast by Type (2020-2025)
10.3 China Biosimilar Market Size and Forecast by Type (2015-2025)
10.3.1 China Biosimilar Market Size by Type (2015-2020)
10.3.2 China Biosimilar Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Biosimilar Market Size by Application (2015-2020)
11.1.1 Global Biosimilar Sales by Application (2015-2020)
11.1.2 Global Biosimilar Revenue by Application (2015-2020)
11.1.3 Global Biosimilar Price by Application (2015-2020)
11.2 Global Biosimilar Market Size and Forecast by Application (2020-2025)
11.2.1 Global Biosimilar Sales and Forecast by Application (2020-2025)
11.2.2 Global Biosimilar Revenue and Forecast by Application (2020-2025)
11.2.3 Global Biosimilar Price and Forecast by Application (2020-2025)
11.3 China Biosimilar Market Size and Forecast by Application (2015-2025)
11.3.1 China Biosimilar Market Size by Application (2015-2020)
11.3.2 China Biosimilar Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Biosimilar Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biosimilar Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Biosimilar Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Allergan plc Basic Information, Manufacturing Base and Competitors
Table 6. Allergan plc Biosimilar Major Business
Table 7. Allergan plc Biosimilar Total Revenue (USD Million) (2018-2019)
Table 8. Allergan plc SWOT Analysis
Table 9. Allergan plc Biosimilar Product and Services
Table 10. Allergan plc Biosimilar Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. Dr. Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 12. Dr. Reddy’s Laboratories Biosimilar Major Business
Table 13. Dr. Reddy’s Laboratories Biosimilar Total Revenue (USD Million) (2018-2019)
Table 14. Dr. Reddy’s Laboratories SWOT Analysis
Table 15. Dr. Reddy’s Laboratories Biosimilar Product and Services
Table 16. Dr. Reddy’s Laboratories Biosimilar Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. BioXpress Therapeutics Basic Information, Manufacturing Base and Competitors
Table 18. BioXpress Therapeutics Biosimilar Major Business
Table 19. BioXpress Therapeutics Biosimilar Total Revenue (USD Million) (2018-2019)
Table 20. BioXpress Therapeutics SWOT Analysis
Table 21. BioXpress Therapeutics Biosimilar Product and Services
Table 22. BioXpress Therapeutics Biosimilar Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. BIOCAD Basic Information, Manufacturing Base and Competitors
Table 24. BIOCAD Biosimilar Major Business
Table 25. BIOCAD Biosimilar Total Revenue (USD Million) (2018-2019)
Table 26. BIOCAD SWOT Analysis
Table 27. BIOCAD Biosimilar Product and Services
Table 28. BIOCAD Biosimilar Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. Coherus BioSciences Basic Information, Manufacturing Base and Competitors
Table 30. Coherus BioSciences Biosimilar Major Business
Table 31. Coherus BioSciences Biosimilar Total Revenue (USD Million) (2018-2019)
Table 32. Coherus BioSciences SWOT Analysis
Table 33. Coherus BioSciences Biosimilar Product and Services
Table 34. Coherus BioSciences Biosimilar Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. Biocon Basic Information, Manufacturing Base and Competitors
Table 36. Biocon Biosimilar Major Business
Table 37. Biocon Biosimilar Total Revenue (USD Million) (2018-2019)
Table 38. Biocon SWOT Analysis
Table 39. Biocon Biosimilar Product and Services
Table 40. Biocon Biosimilar Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 41. Intas Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table 42. Intas Pharmaceuticals Limited Biosimilar Major Business
Table 43. Intas Pharmaceuticals Limited Biosimilar Total Revenue (USD Million) (2018-2019)
Table 44. Intas Pharmaceuticals Limited SWOT Analysis
Table 45. Intas Pharmaceuticals Limited Biosimilar Product and Services
Table 46. Intas Pharmaceuticals Limited Biosimilar Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 47. Celltrion Basic Information, Manufacturing Base and Competitors
Table 48. Celltrion Biosimilar Major Business
Table 49. Celltrion Biosimilar Total Revenue (USD Million) (2018-2019)
Table 50. Celltrion SWOT Analysis
Table 51. Celltrion Biosimilar Product and Services
Table 52. Celltrion Biosimilar Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 53. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 54. Boehringer Ingelheim Biosimilar Major Business
Table 55. Boehringer Ingelheim Biosimilar Total Revenue (USD Million) (2018-2019)
Table 56. Boehringer Ingelheim SWOT Analysis
Table 57. Boehringer Ingelheim Biosimilar Product and Services
Table 58. Boehringer Ingelheim Biosimilar Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 59. Genor BioPharma Basic Information, Manufacturing Base and Competitors
Table 60. Genor BioPharma Biosimilar Major Business
Table 61. Genor BioPharma Biosimilar Total Revenue (USD Million) (2018-2019)
Table 62. Genor BioPharma SWOT Analysis
Table 63. Genor BioPharma Biosimilar Product and Services
Table 64. Genor BioPharma Biosimilar Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 65. Novartis Basic Information, Manufacturing Base and Competitors
Table 66. Novartis Biosimilar Major Business
Table 67. Novartis Biosimilar Total Revenue (USD Million) (2018-2019)
Table 68. Novartis SWOT Analysis
Table 69. Novartis Biosimilar Product and Services
Table 70. Novartis Biosimilar Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 71. Pfizer Basic Information, Manufacturing Base and Competitors
Table 72. Pfizer Biosimilar Major Business
Table 73. Pfizer Biosimilar Total Revenue (USD Million) (2018-2019)
Table 74. Pfizer SWOT Analysis
Table 75. Pfizer Biosimilar Product and Services
Table 76. Pfizer Biosimilar Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 77. Reliance Life Sciences Basic Information, Manufacturing Base and Competitors
Table 78. Reliance Life Sciences Biosimilar Major Business
Table 79. Reliance Life Sciences Biosimilar Total Revenue (USD Million) (2018-2019)
Table 80. Reliance Life Sciences SWOT Analysis
Table 81. Reliance Life Sciences Biosimilar Product and Services
Table 82. Reliance Life Sciences Biosimilar Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 83. Global Biosimilar Sales by Manufacturer (2018-2019) (K g)
Table 84. Global Biosimilar Revenue by Manufacturer (2018-2019) (USD Million)
Table 85. Key Players Biosimilar Sales in China (2018-2019) (K g)
Table 86. Key Players Biosimilar Sales Market Share in China (2018-2019)
Table 87. Key Players Revenue of Biosimilar in China (2018-2019) (USD Million)
Table 88. Global Biosimilar Sales by Regions (2015-2020) (K g)
Table 89. Global Biosimilar Sales Market Share by Regions (2015-2020)
Table 90. Global Biosimilar Revenue by Regions (2015-2020) (USD Million)
Table 91. Global Biosimilar Sales and Forecast by Regions (2020-2025) (K g)
Table 92. Global Biosimilar Sales Market Share by Regions (2020-2025)
Table 93. Global Biosimilar Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 94. Global Biosimilar Revenue Market Share by Regions (2020-2025) (USD Million)
Table 95. North America Biosimilar Sales by Countries (2015-2020) (K g)
Table 96. North America Biosimilar Sales Market Share by Countries (2015-2020)
Table 97. North America Biosimilar Revenue by Countries (2015-2020) (USD Million)
Table 98. North America Biosimilar Revenue Market Share by Countries (2015-2020)
Table 99. North America Biosimilar Sales by Country (2020-2025) (K g)
Table 100. North America Biosimilar Sales Market Share by Country (2020-2025)
Table 101. North America Biosimilar Revenue by Country (2020-2025) (USD Million)
Table 102. North America Biosimilar Revenue Market Share by Country (2020-2025)
Table 103. Europe Biosimilar Sales by Countries (2015-2020) (K g)
Table 104. Europe Biosimilar Sales Market Share by Countries (2015-2020)
Table 105. Europe Biosimilar Revenue by Countries (2015-2020) (USD Million)
Table 106. Europe Biosimilar Revenue Market Share by Countries (2015-2020)
Table 107. Europe Biosimilar Sales by Country (2020-2025) (K g)
Table 108. Europe Biosimilar Sales Market Share by Country (2020-2025)
Table 109. Europe Biosimilar Revenue by Country (2020-2025) (USD Million)
Table 110. Europe Biosimilar Revenue Market Share by Country (2020-2025)
Table 111. Asia-Pacific Biosimilar Sales by Countries (2015-2020) (K g)
Table 112. Asia-Pacific Biosimilar Sales Market Share by Countries (2015-2020)
Table 113. Asia-Pacific Biosimilar Revenue by Countries (2015-2020) (USD Million)
Table 114. Asia-Pacific Biosimilar Revenue Market Share by Countries (2015-2020)
Table 115. Asia-Pacific Biosimilar Sales by Country (2020-2025) (K g)
Table 116. Asia-Pacific Biosimilar Sales Market Share by Country (2020-2025)
Table 117. Asia-Pacific Biosimilar Revenue by Country (2020-2025) (USD Million)
Table 118. Asia-Pacific Biosimilar Revenue Market Share by Country (2020-2025)
Table 119. South America Biosimilar Sales by Countries (2015-2020) (K g)
Table 120. South America Biosimilar Sales Market Share by Countries (2015-2020)
Table 121. South America Biosimilar Revenue by Countries (2015-2020) (USD Million)
Table 122. South America Biosimilar Revenue Market Share by Countries (2015-2020)
Table 123. South America Biosimilar Sales by Country (2020-2025) (K g)
Table 124. South America Biosimilar Sales Market Share by Country (2020-2025)
Table 125. South America Biosimilar Revenue by Country (2020-2025) (USD Million)
Table 126. South America Biosimilar Revenue Market Share by Country (2020-2025)
Table 127. Middle East & Africa Biosimilar Sales by Countries (2015-2020) (K g)
Table 128. Middle East & Africa Biosimilar Sales Market Share by Countries (2015-2020)
Table 129. Middle East & Africa Biosimilar Revenue by Countries (2015-2020) (USD Million)
Table 130. Middle East & Africa Biosimilar Revenue Market Share by Countries (2015-2020)
Table 131. Middle East & Africa Biosimilar Sales by Country (2020-2025) (K g)
Table 132. Middle East & Africa Biosimilar Sales Market Share by Country (2020-2025)
Table 133. Middle East & Africa Biosimilar Revenue by Country (2020-2025) (USD Million)
Table 134. Middle East & Africa Biosimilar Revenue Market Share by Country (2020-2025)
Table 135. China Biosimilar Sales by Type (2015-2020) (K g)
Table 136. China Biosimilar Sales Market Share by Type (2015-2020)
Table 137. China Biosimilar Revenue by Type (2015-2020) (USD Million)
Table 138. China Biosimilar Revenue Market Share by Type (2015-2020)
Table 139. China Biosimilar Sales by Type (2020-2025) (K g)
Table 140. China Biosimilar Sales Market Share by Type (2020-2025)
Table 141. China Biosimilar Revenue by Type (2020-2025) (USD Million)
Table 142. China Biosimilar Revenue Market Share by Type (2020-2025)
Table 143. Global Biosimilar Sales by Application (2015-2020) (K g)
Table 144. Global Biosimilar Sales Market Share by Application (2015-2020)
Table 145. Global Biosimilar Revenue by Application (2015-2020) (USD Million)
Table 146. Global Biosimilar Revenue Market Share by Application (2015-2020)
Table 147. Global Biosimilar Price by Application (2015-2020) (USD/Unit)
Table 148. Global Biosimilar Sales by Application (2020-2025) (K g)
Table 149. Global Biosimilar Sales Market Share by Application (2020-2025)
Table 150. Global Biosimilar Revenue by Application (2020-2025) (USD Million)
Table 151. Global Biosimilar Revenue Market Share by Application (2020-2025)
Table 152. Global Biosimilar Price by Application (2020-2025) (USD/Unit)
Table 153. China Biosimilar Sales by Application (2015-2020) (K g)
Table 154. China Biosimilar Sales Market Share by Application (2015-2020)
Table 155. China Biosimilar Revenue by Application (2015-2020) (USD Million)
Table 156. China Biosimilar Revenue Market Share by Application (2015-2020)
Table 157. China Biosimilar Sales by Application (2020-2025) (K g)
Table 158. China Biosimilar Sales Market Share by Application (2020-2025)
Table 159. China Biosimilar Revenue by Application (2020-2025) (USD Million)
Table 160. China Biosimilar Revenue Market Share by Application (2020-2025)
Table 161. Direct Channel Pros & Cons
Table 162. Indirect Channel Pros & Cons
Table 163. Distributors/Traders/ Dealers List
Table 164. Customers of Biosimilar
Table 165. Market Opportunities in Next Few Years
Table 166. Market Risks Analysis
Table 167. Market Drivers

List of Figures

Figure 1. Biosimilar Picture
Figure 2. Global Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Human Growth Hormones Picture
Figure 4. Monoclonal Antibodies Picture
Figure 5. Insulin Picture
Figure 6. Peptides Picture
Figure 7. Erythropoietin Picture
Figure 8. Others Picture
Figure 9. Biosimilar Sales Market Share by Application in 2019
Figure 10. Oncology Picture
Figure 11. Chronic and Autoimmune Diseases Picture
Figure 12. Growth Hormone Deficiency Picture
Figure 13. Infectious Diseases Picture
Figure 14. Others Picture
Figure 15. Global Biosimilar Market Status and Outlook (2015-2025) (USD Million)
Figure 16. Global Biosimilar Sales Growth Rate (2015-2025) (K g)
Figure 17. Global Biosimilar Sales Market Share by Manufacturer in 2019
Figure 18. Global Biosimilar Revenue Market Share by Manufacturer in 2019
Figure 19. Key Players Biosimilar Revenue Market Share in China in 2019
Figure 20. Global Top 5 Biosimilar Manufacturer Market Share in 2019
Figure 21. Top 3 Biosimilar Players Market Share in China in 2019
Figure 22. Global Biosimilar Revenue Market Share by Regions in 2019
Figure 23. North America Biosimilar Sales YoY Growth (2015-2025) (K g)
Figure 24. North America Biosimilar Revenue YoY Growth (2015-2025) (USD Million)
Figure 25. Europe Biosimilar Sales YoY Growth (2015-2020) (K g)
Figure 26. Europe Biosimilar Revenue YoY Growth (2015-2020) (USD Million)
Figure 27. Asia-Pacific Biosimilar Sales YoY Growth (2015-2020) (K g)
Figure 28. Asia-Pacific Biosimilar Revenue YoY Growth (2015-2020) (USD Million)
Figure 29. South America Biosimilar Sales YoY Growth (2015-2020) (K g)
Figure 30. South America Biosimilar Revenue YoY Growth (2015-2020) (USD Million)
Figure 31. Middle East & Africa Biosimilar Sales YoY Growth (2015-2020) (K g)
Figure 32. Middle East & Africa Biosimilar Revenue YoY Growth (2015-2020) (USD Million)
Figure 33. North America Biosimilar Sales Market Share by Country in 2019
Figure 34. North America Biosimilar Revenue Market Share by Country in 2019
Figure 35. United States Biosimilar Market Size and Growth Rate (2015-2025) (USD Million)
Figure 36. Canada Biosimilar Market Size and Growth Rate (2015-2025) (USD Million)
Figure 37. Mexico Biosimilar Market Size and Growth Rate (2015-2020) (USD Million)
Figure 38. Europe Biosimilar Revenue Market Share by Country in 2019
Figure 39. Germany Biosimilar Market Size Growth Rate (2015-2025) (USD Million)
Figure 40. United Kingdom Biosimilar Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. France Biosimilar Market Size Growth Rate (2015-2025) (USD Million)
Figure 42. Russia Biosimilar Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. Italy Biosimilar Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Asia-Pacific Biosimilar Sales Market Share by Region 2018
Figure 45. Asia-Pacific Biosimilar Revenue Market Share by Region 2018
Figure 46. China Biosimilar Market Size Growth Rate (2015-2025) (USD Million)
Figure 47. Japan Biosimilar Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. Korea Biosimilar Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. India Biosimilar Market Size Growth Rate (2015-2025) (USD Million)
Figure 50. Southeast Asia Biosimilar Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Australia Biosimilar Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. South America Biosimilar Sales Market Share by Country in 2019
Figure 53. South America Biosimilar Revenue Market Share by Country in 2019
Figure 54. Brazil Biosimilar Market Size Growth Rate (2015-2025) (USD Million)
Figure 55. Argentina Biosimilar Market Size Growth Rate (2015-2025) (USD Million)
Figure 56. Saudi Arabia Biosimilar Market Size Growth Rate (2015-2025) (USD Million)
Figure 57. Turkey Biosimilar Market Size Growth Rate (2015-2025) (USD Million)
Figure 58. Egypt Biosimilar Market Size Growth Rate (2015-2025) (USD Million)
Figure 59. South Africa Biosimilar Market Size Growth Rate (2015-2025) (USD Million)
Figure 60. Global Revenue Market Share of Biosimilar by Type in 2019
Figure 61. Global Revenue Market Share of Biosimilar by Application in 2019
Figure 62. Sales Channel: Direct Channel vs Indirect Channel

Table of Contents

Related reports :

(Mar 20)

Market Overview The global Artesunate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CA...

(Mar 20)

Market Overview The global Plant Sources Anti Cancer Agents market size is expected to gain market growth in the forecast period of 2...

(Mar 20)

Market Overview The global Hydroxycamptothecin market size is expected to gain market growth in the forecast period of 2020 to 2025, ...

(Mar 20)

Market Overview The global Irinotecan market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CA...

(Mar 20)

Market Overview The global Medical Protective Packaging market size is expected to gain market growth in the forecast period of 2020 ...

(Mar 20)

Market Overview The global Vinorelbine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a C...

Global Info Research

GLOBAL AND CHINA BIOSIMILAR MARKET 2020 BY MANUFACTURERS, TYPE AND APPLICATION, FORECAST TO 2025

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy